0.05Open0.05Pre Close0 Volume1 Open Interest0.50Strike Price0.00Turnover608.92%IV76.32%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0379Delta0.0401Gamma38.00Leverage Ratio-0.0073Theta0.0000Rho-1.44Eff Leverage0.0003Vega
Reviva Pharmaceuticals Stock Discussion
GlobeNewswire· 6 mins ago
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia
Monday, 16th December at 8:00 am
– Once daily brilaroxazine demonstrated favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year –
– Generally well-tolerated with low rates of adverse events and discontinuation –
– Full data set from open-label extension (OLE) of R...
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
📊⚡️📊
📊⚡️📊
📊⚡️📊
No comment yet